<DOC>
	<DOCNO>NCT02061995</DOCNO>
	<brief_summary>Osteoporosis systemic skeletal disease characterize low bone mass microarchitectural deterioration bone tissue , subsequent increase bone fragility susceptibility fracture . Osteoporosis one common debilitate chronic disease , global health concern high prevalence Western country , also Asia Latin America . Most efficacious anti-osteoporotic treatment either inhibit bone resorption like bisphosphonates denosumab increase bone formation like teripartide anabolic agent . Anti-osteoporotic drug demonstrate safety efficacy increase bone mass decrease fracture risk ( hip ) 30 50 % 3 year treatment ( Black et al. , 1996 ; Neer et al. , 2001 ; Meunier et al. , 2004 ) . Despite availability pharmacological treatment , osteoporosis remain significant health problem patient respond available treatment fail comply regimen . The present phase 2a study aim demonstrate safety efficacy PREOBÂ® , proprietary population autologous osteoblastic cell , treatment osteoporotic patient respond pharmacological treatment .</brief_summary>
	<brief_title>Phase 2a Study Intravenous Infusion Autologous Osteoblastic Cells Severe Osteoporosis</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<criteria>Diagnosis severe osteoporosis Nonresponse antiosteoporotic treatment 2 year Normal hematology function Ability provide write , date , sign informed consent prior study related procedure , understand comply study requirement Positive serology hepatitis B , hepatitis C , HIV , syphilis , HTLV1 Current past medical disease could interfere evaluation efficacy , judge investigator Severe renal hepatic impairment</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Bone Diseases</keyword>
	<keyword>Metabolic Bone Diseases</keyword>
	<keyword>Osteoporosis</keyword>
	<keyword>Bone Fractures</keyword>
	<keyword>Osteoporotic Fractures</keyword>
	<keyword>Musculoskeletal Diseases</keyword>
</DOC>